Lead-associated Superior Vena Cava Syndrome
| Autor: | Andre d'Avila, Kelsey Murphy, Tyler Mehegan, Andrew Locke, Jessica Burr, Peter Zimetbaum, Marc L. Schermerhorn, David J Shim |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Superior vena cava syndrome venoplasty business.industry superior vena cava syndrome SVC SYNDROME Case Report Venous Obstruction Transvenous lead Anticoagulation QRS complex cardiovascular implantable electronic device Superior vena cava Physiology (medical) Internal medicine cardiovascular system medicine Cardiology medicine.symptom Cardiology and Cardiovascular Medicine Lead (electronics) Complication business device extraction |
| Zdroj: | The Journal of Innovations in Cardiac Rhythm Management |
| ISSN: | 2156-3993 2156-3977 |
| DOI: | 10.19102/icrm.2021.120404 |
| Popis: | Superior vena cava (SVC) syndrome is a rare complication associated with transvenous cardiac implantable electronic devices that may present with a variety of manifestations. Various strategies such as transvenous lead extraction, anticoagulation, venoplasty, and stenting have been used to treat this condition, but the optimal management protocols have yet to be defined. Subcutaneous implantable cardioverter-defibrillator (ICD) (S-ICD) therapy can be an alternative option to a transvenous system for those who require future ICD surveillance. We present a case of lead-associated SVC syndrome where thoracic venous congestion due to SVC obstruction influenced preimplant S-ICD QRS vector screening. Following treatment of venous obstruction, QRS amplitude may change and patients who were not initially S-ICD candidates may later become eligible. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|